WU Jun-wei. Clinical Evaluation on Fufang Biejia Ruangan Tablets and Mangan Jieyu Capsules for Treating Cirrhosis after Hepatitis[J]. Chinese journal of experimental traditional medical formulae, 2013, 19(5): 327-329.
WU Jun-wei. Clinical Evaluation on Fufang Biejia Ruangan Tablets and Mangan Jieyu Capsules for Treating Cirrhosis after Hepatitis[J]. Chinese journal of experimental traditional medical formulae, 2013, 19(5): 327-329. DOI: 10.13422/j.cnki.syfjx.2013.05.024.
Objective:To study the clinical curative effect and the influence of the life quality of Fufang Biejia Ruangan tablets(FBRT) and Mangan Jieyu capsules(MJC) for treating cirrhosis after hepatitis(compensatory period).Method: Seventy-four cases of cirrhosis after hepatitis were randomly divided into the treatment group(n=35) and the control group(n=39).Two groups were given conventional liver-protecting drugs and antiviral treatment
meanwhile the treatment group was treated by FBRT 4 tablets tid
MJC 4 capsules tid.The course of treatment was 24 weeks.Clinical symptoms
life quality
hyaluronic acid(HA)
laminin(LN)
type Ⅲ procollagen(PC Ⅲ)
type IV collagen(IV-C) were observed and determined.Result: After treatment(12
24 weeks) clinical symptoms scores in the treatment group were lower than those in control group(P<0.01).HA
LN
PC Ⅲ and IV-C in the treatment group were lower than those of the control group(P<0.05
P<0.01).The total scores in physiological
psychological and social aspects in treatment group were significantly higher than those in the control group(P<0.05
P<0.01).The effective rate was 87.18% in the treatment group
and 65.71% in the controls(P<0.05).Conclusion: For treating cirrhosis after hepatitis(compensatory period)
FBRT and MJC can obviously relieve clinical symptoms